The Dutch Symptom Checklist-90-Revised:Is the Use of the Subscales Justified?

The Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977, 1994) was constructed to measure both general psychological distress and specific primary symptoms of distress. In this study, we evaluated to what extent the scale scores of the Dutch SCL-90-R reflect general and/or specific aspects of psychological distress in a psychiatric outpatients sample (N = 1,842), using a hierarchical factor model. The results revealed that the total scale score measures general psychological distress, with high reliability. The subscale scores Sleep Difficulties, Agoraphobia, Hostility, and Somatization reflect the specific primary symptoms reasonably well, with high reliability. The subscale score Depression hardly measures specific symptoms of distress, but instead a very common construct as is measured with the total scale of the SCL-90-R. The use of the Depression subscale score beyond the total scale score of the SCL-90-R appears therefore of limited value in clinical practice

Data from ‘Cohort Differences in Big Five Personality Factors Over a Period of 25 Years’

This data set comprises of scores of 8,954 psychology freshmen from the University of Amsterdam (1982-2007) on the ‘Vijf PersoonlijkheidsFactoren Test’ or 5PFT developed by Elshout and Akkerman, which is an instrument to measure the Big Five personality factors Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness to Experience. Data were collected during the yearly freshmen-testing program from 1982-2007 and include scores at the level of 70 items that can be used in studies of psychometrics and the nature of personality

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.

BACKGROUND: The T2-FLAIR mismatch sign is defined by signal loss of the T2-weighted hyperintense area with Fluid-Attenuated Inversion Recovery (FLAIR) on magnetic resonance imaging, causing a hypointense region on FLAIR. It is a highly specific diagnostic marker for IDH-mutant astrocytoma and is postulated to be caused by intercellular microcystic change in the tumor tissue. However, not all IDH-mutant astrocytomas show this mismatch sign and some show the phenomenon in only part of the lesion. The aim of the study is to determine whether the T2-FLAIR mismatch phenomenon has any prognostic value beyond initial noninvasive molecular diagnosis. METHODS: Patients initially diagnosed with histologically lower-grade (2 or 3) IDH-mutant astrocytoma and with at least 2 surgical resections were included in the GLASS-NL cohort. T2-FLAIR mismatch was determined, and the growth pattern of the recurrent tumor immediately before the second resection was annotated as invasive or expansive. The relation between the T2-FLAIR mismatch sign and tumor grade, microcystic change, overall survival (OS), and other clinical parameters was investigated both at first and second resection. RESULTS: The T2-FLAIR mismatch sign was significantly related to Grade 2 (80% vs 51%), longer post-resection median OS (8.3 vs 5.2 years), expansive growth, and lower age at second resection. At first resection, no relation was found between the mismatch sign and OS. Microcystic change was associated with areas of T2-FLAIR mismatch. CONCLUSIONS: T2-FLAIR mismatch in IDH-mutant astrocytomas is correlated with microcystic change in the tumor tissue, favorable prognosis, and Grade 2 tumors at the time of second resection